I see that now. Also, their lead drug, MuGard, received 510(k) marketing approval in the U.S., which I thought was strange as it sounds more like a drug than a device. MuGard is referred to as a "viscous, mucoadhesive rinse" on their Web site. Anyways, the data for the "device" references improvements over historical controls, which can't give one a lot of confidence. All told, ACCP is not looking like a company worthy of any more research.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.